Jeffrey W. Sherman, EVP and Chief Medical Officer at Horizon Pharma plc (HZNP), sold 26,887 shares at $35.55 ($956K) on 2015-07-15, disclosed to the SEC on 2015-07-17.
Scheduled sale ($956k) by EVP and Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.55 | 2,450 | $87K | 9.1% |
| 2 | $35.55 | 24,437 | $869K | 90.9% |
| Total | $35.55 avg | 26,887 | $956K | 100% |
| Filing → |
| XERS | BUY | 2023-11-29 | $10K | — | Filing → |
| HZNP | SELL | 2023-01-12 | $1.5M | — | Filing → |
| HZNP | SELL | 2023-01-06 | $1.2M | — | Filing → |